Navigation Links
Hypertension Not Given Priority during Treatment

According to a study it was found that physicians do not change the treatment for patients suffering from uncontrolled hypertension//. But it is also found that hypertension leads to cardiovascular risks.

The findings were presented in New York City at the 21st Annual Scientific Meeting of the American Society of Hypertension (ASH 2006) for the CONTROL PROJECT study group by Dr. Antonio Coca of the Hypertension Unit at the Hospital Clinic of the University Of Barcelona, Spain. ‘The results show that there is a significant lack of concern among primary care physicians about the importance of hypertension treatment in patients at high risk of cardiovascular disease,’ he said.

The CONTROL PROJECT was a cross-sectional, national multi-center study in Spain that followed 1,413 patients with treated and uncontrolled hypertension seen by 356 primary care physicians. The patients, just over half of them women (55.2%), with a mean age of just over 65, were assessed according to European Society of Hypertension 2003 guidelines.

A majority of them were judged to be at either very high (34.5%) or high (29.4%) cardiovascular risk, with a high prevalence of associated cardiovascular risk factors such as overweight (53.7%), hyperlipidemia (52.2%), diabetes (39.5%) and family history of cardiovascular disease (15.7%). In addition, one-fifth of the patients (20.3%) had left ventricular hypertrophy (enlarged hearts) and more than one-in-ten (12.8%) had microalbuminuria, an indicator of subclinical cardiovascular disease.

Despite having blood pressure that was not controlled with treatment (blood pressure higher than 140/90 mmHg or higher than 130/80 mmHg in diabetics), 41.6% of the patients were still treated with just a single antihypertensive drug, and less than half of their primary care physicians (45%) recommended a change in their treatment, either increasing the dose of the single drug being taken (17.55%) or adding an additional drug an d/or prescribing a fixed combination compound (35%). Nearly one-in-three of the primary care physicians (30%) considered that no change was required, and nearly two-thirds (65%) suggested improving compliance to non-pharmacological changes such as diet and exercise. And, only about half (56%) of the physicians asked patients to come in for a new control visit within 2-3 weeks.

Source: Newswise
'"/>




Related medicine news :

1. New viewpoint on Hypertension
2. Hypertension drugs could lower Disability
3. FDA Approves Remodulin for Pulmonary Hypertension
4. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
5. Hypertension lowered by Bedtime Dosing
6. Better Treatment For Hypertension
7. Treating Pulmonary Arterial Hypertension In Children With Viagra
8. Hypertension Drug of Choice for African Americans
9. Hypertension can be caused by Inhalation of Salt
10. Inhaling Salt Can Lead To Hypertension
11. Elderly Women Remain At Risk From Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: